Oxcarbazepine
Product Images NDC 70518-4507

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Oxcarbazepine Tablet 300 mg packaging label showing a quantity of 30 tablets. The label includes the NDC number 70518-4507-00, manufacturer information (Breckenridge, Boca Raton, FL), and storage instructions. It also identifies the tablet as oval brown with the code B293. The label is from RemedyRepack Inc., Indiana, PA, and is marked RX only.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure diagram of oxcarbazepine showing its molecular framework with two benzene rings attached to a seven-membered ring containing a ketone and amide group.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This is a survival curve chart showing the exit rate over time from Day 2 to Day 11 comparing two treatment groups: Oxcarbazepine and Placebo. The x-axis represents time on trial in days, and the y-axis shows the exit rate from 0.0 to 1.0. The chart includes a log-rank test p-value of 0.0001, indicating a statistical comparison between groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier curve graph showing seizure rate over days from the first dose to first seizure for two treatment groups: Oxcarbazepine (solid line) and Placebo (dotted line). The y-axis represents seizure rate, ranging from 0 to 1.0, and the x-axis shows days up to 140. The graph includes a log-rank test p-value of 0.046, indicating comparison between the two groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A line chart depicting exit rate over time in days for two treatment groups labeled HIGH and LOW. The exit rate ranges from 0 to 1, with the LOW group showing a steeper increase and higher exit rate earlier compared to the HIGH group. A log-rank test p-value of 0.0001 is displayed, indicating a statistical comparison between groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier plot chart depicting exit rate over time in days, comparing two treatment groups labeled HIGH (solid line) and LOW (dotted line). The y-axis represents exit rate (0 to 1.0), and the x-axis represents time to exit in days (0 to 130). A log-rank test with p-value 0.0001 is noted on the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.